Achieve Life Sciences, Inc.
ACHV· Nasdaq
Filed Mar 8, 2012 · 10-K · 68 days after period end · 0001193125-12-103884
| Metric | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|
| Net Income | -$9.57M | — |
| EPS Diluted | -$0.98 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Achieve Life Sciences, Inc. · CIK 949858 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 8, 2012 · 68 d after period end